The DMRT3 (Doublesex and Mab-3 Related Transcription Factor 3) antibody is a key tool for studying the role of the DMRT3 protein, a member of the evolutionarily conserved DMRT family involved in sex determination, neuronal development, and locomotor circuitry. DMRT3 is notably associated with spinal cord interneuron differentiation, particularly in circuits controlling limb coordination and gait patterns. Research in horses has linked DMRT3 mutations to altered ambling gaits, highlighting its importance in vertebrate locomotion. The antibody, typically developed in rabbits or mice, detects endogenous DMRT3 proteins via techniques like Western blotting, immunohistochemistry, or immunofluorescence. Its specificity is validated using knockout controls or siRNA-mediated silencing. Studies utilizing this antibody have advanced understanding of neural circuit assembly, genetic mechanisms underlying movement disorders, and interspecies gait variation. Commercial DMRT3 antibodies are often tested in model organisms (e.g., mice, chickens) and humans, with applications spanning developmental biology, neuroscience, and veterinary genetics. Proper validation remains critical due to potential cross-reactivity with other DMRT family members. Recent work also explores DMRT3’s role beyond locomotion, including potential functions in cancer and sexual dimorphism, underscoring the antibody’s versatility in multidisciplinary research.